Phytopharm PLC
26 January 2005
Not for release, publication or distribution, directly or indirectly, in or into
the United States, Canada, Australia, Japan or the Republic of Ireland
For immediate release
Phytopharm plc
The Board of Phytopharm plc (the 'Company') notes the recent share price
movement and press speculation.
The Company confirms that following recent positive events it is in advanced
discussions to raise additional finance by way of a material equity placing and
open offer to further develop and exploit the potential of its product
candidates.
Enquiries:
Financial Dynamics
David Yates/Ben Atwell
Tel: +44 20 7831 3113
These written materials are not for distribution in the United States. These
written materials are not an offer of securities for sale in the United States.
Securities may not be offered or sold in the United States absent registration
under the US Securities Act or an exemption therefrom. Phytopharm plc has not
and does not intend to register any of the securities under the US Securities
Act. The securities will not be offered or sold to the public in the United
States of America.
This information is provided by RNS
The company news service from the London Stock Exchange
SPMSESFEMSISEEF

